Patents Assigned to Pellficure Pharmaceuticals, Inc.
  • Compositions and methods for treatment of prostate carcinoma
    Patent number: 10577315
    Abstract: Disclosed herein are 1,4-naphthoquinone analogs, pharmaceutical compositions that include one or more of such 1,4-naphthoquinone analogs, and methods of treating and/or ameliorating diseases and/or conditions associated with a cancer, such as prostate cancer with such 1,4-naphthoquinone analogs. Also included are combination therapies wherein a 1,4-naphthoquinone analog disclosed herein, and a hormone therapy agent are provided to a subject suffering from a condition such as cancer.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: March 3, 2020
    Assignee: PELLFICURE PHARMACEUTICALS, INC.
    Inventors: Per Borgström, Adrian Chrastina, Veronique Therese Baron, Parisa Abedinpour
  • Treatment of prostate carcinoma
    Patent number: 10245240
    Abstract: Disclosed herein are naphthoquinone analogs, such as plumbagin, pharmaceutical compositions that include naphthoquinone analogs, such as plumbagin, and methods of treating diseases and/or conditions such as cancer with naphthoquinone analogs, such as plumbagin. Also included are combination therapies wherein a naphthoquinone analog, such as plumbagin, and a hormone therapy agent are provided to a subject suffering from a condition such as cancer.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: April 2, 2019
    Assignee: PELLFICURE PHARMACEUTICALS, INC.
    Inventor: Per Borgström
  • Compositions and methods for treatment of prostate carcinoma
    Patent number: 10093620
    Abstract: Disclosed herein are 1,4-naphthoquinone analogs, pharmaceutical compositions that include one or more of such 1,4-naphthoquinone analogs, and methods of treating and/or ameliorating diseases and/or conditions associated with a cancer, such as prostate cancer with such 1,4-naphthoquinone analogs. Also included are combination therapies wherein a 1,4-naphthoquinone analog disclosed herein, and a hormone therapy agent are provided to a subject suffering from a condition such as cancer.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: October 9, 2018
    Assignee: PELLFICURE PHARMACEUTICALS, INC.
    Inventors: Per Borgström, Adrian Chrastina, Veronique Therese Baron, Parisa Abedinpour
  • Treatment of prostate carcinoma
    Patent number: 9877932
    Abstract: Disclosed herein are naphthoquinone analogs, such as plumbagin, pharmaceutical compositions that include naphthoquinone analogs, such as plumbagin, and methods of treating diseases and/or conditions such as cancer with naphthoquinone analogs, such as plumbagin. Also included are combination therapies wherein a naphthoquinone analog, such as plumbagin, and a hormone therapy agent are provided to a subject suffering from a condition such as cancer.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: January 30, 2018
    Assignee: Pellficure Pharmaceuticals, Inc.
    Inventor: Per Borgström
  • Treatment of prostate carcinoma
    Patent number: 9655868
    Abstract: Disclosed herein are naphthoquinone analogs, such as plumbagin, pharmaceutical compositions that include naphthoquinone analogs, such as plumbagin, and methods of treating diseases and/or conditions such as cancer with naphthoquinone analogs, such as plumbagin. Also included are combination therapies wherein a naphthoquinone analog, such as plumbagin, and a hormone therapy agent are provided to a subject suffering from a condition such as cancer.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: May 23, 2017
    Assignee: Pellficure Pharmaceuticals, Inc.
    Inventor: Per Borgström
  • Treatment of prostate carcinoma
    Patent number: 9132105
    Abstract: Disclosed herein are naphthoquinone analogs, such as plumbagin, pharmaceutical compositions that include naphthoquinone analogs, such as plumbagin, and methods of treating diseases and/or conditions such as cancer with naphthoquinone analogs, such as plumbagin. Also included are combination therapies wherein a naphthoquinone analog, such as plumbagin, and a hormone therapy agent are provided to a subject suffering from a condition such as cancer.
    Type: Grant
    Filed: August 3, 2011
    Date of Patent: September 15, 2015
    Assignee: Pellficure Pharmaceuticals, Inc.
    Inventor: Per Borgström
  • NOVEL TREATMENT OF PROSTATE CARCINOMA
    Publication number: 20130219528
    Abstract: Disclosed herein are naphthoquinone analogs, such as plumbagin, pharmaceutical compositions that include naphthoquinone analogs, such as plumbagin, and methods of treating diseases and/or conditions such as cancer with naphthoquinone analogs, such as plumbagin. Also included are combination therapies wherein a naphthoquinone analog, such as plumbagin, and a hormone therapy agent are provided to a subject suffering from a condition such as cancer.
    Type: Application
    Filed: August 3, 2011
    Publication date: August 22, 2013
    Applicant: Pellficure Pharmaceuticals, Inc.
    Inventor: Per Borgström